Laboratorios Farmacéuticos ROVI

Pharmaceutical Research and Manufacturing

Laboratorios Farmacéuticos ROVI, S.A. is a Spanish pharmaceutical company involved in research, development, manufacturing, and commercialization. Its operations are organized around three areas: specialty medicines, contract development and manufacturing (CDMO), and low-molecular-weight heparins.

Business Areas

• Specialty medicines: a diversified portfolio of innovative proprietary products and products marketed under license, protected by patents.
• Low-molecular-weight heparin (LMWH): its main product, developed in-house and available in more than 60 countries through strategic partnerships with international partners.
• CDMO: contract manufacturing at three production plants for prefilled syringes and oral solid dosage forms.
• Biosimilars: a growth area in a European market valued at more than €1 billion.

Company Figures and Activity

According to company-published figures, ROVI recorded €743.5 million in operating revenue in 2025, including €473.9 million from specialty medicines and €269.5 million from CDMO sales. R&D investment in 2025 was €37.8 million, up 47% from 2024. ROVI is publicly traded and provides information for shareholders and investors, including communications to the Spanish National Securities Market Commission (CNMV).

International Offices

ROVI has offices in several countries:

• Madrid, main office: Calle José Isbert, 2, 28223 Pozuelo de Alarcón, Madrid, Spain. Phone: +34 91 021 30 00. Email: rovi@rovi.es
• Barcelona: Travesera de Gracia, 415–417, 08025 Barcelona, Spain
• France: Rue du Drac, 24, 38180 Seyssins
• Germany: Rudolf-Diesel-Ring, 6, 83607 Holzkirchen
• Italy: Viale Achille Papa, 30, 20149 Milan
• United Kingdom: One Elmfield Park, Office 2.06, Bromley, BR1 1LU
• Portugal: Alameda Fernão Lopes 16, 12º direito, 1495-190 Algés. Phone: +351 21 310 56 10. Email: geral@rovi.com

The company lists a registered address for data-protection matters at Calle Julián Camarillo, 35, 28037 Madrid, with phone number 91 375 62 30.

Customers and Partners

ROVI combines its own industrial capacity with contract manufacturing services, serving both customers looking for specialty medicines and companies seeking CDMO services. Its main product, low-molecular-weight heparin, is marketed internationally through agreements with local partners.